chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This was basically a continuation of symptoms from the 1st dose of Moderna. I was seen two days later for another outbreak of Gottron's papules on my hands and feet. Also, I was listed as a potential Dermatomyositis patient in hopes that it would narrow down my autoimmune issue. I had a bunch of specialist visits and nothing really came up in terms of diagnosis but there were a lot of tests done. I was seen in rheumatology, dermatology, epilepsy lab and Ob-gyn and radiology. Since then, I haven't had any other Gottron's papules flare ups since then but also I haven't had any other vaccines since. They still don't know what is causing my seizures and what is causing my body to go into flare ups. However, they have turned me over to a therapist to deal with my stress levels because they think my stress levels coincide with my loss of consciousness. After all this, they determined I was allergic to cats, dogs, guinea pigs, tree pollen and dust mites. I have had numerous seizures throughout this time period but they appear to be less frequent as time passes.
Patient states arm is still sore one month after receiving vaccine - now pain radiating to neck and knee.
Patient reports check tightness, anxiety.  Patient was treated by EMS and nurses on site. Patients symptoms resolved and patient left site via personal vehicle.
Unprovoked bilateral pulmonary embolism   Impression: multiple bilateral pulmonary emboli and proximol of which are in the right interlobar right middle lobar, right lower lobar and left lobar arteries.  there is also multiple bilateral segmental pulmonary  emboli. there is no CT evidence of pulmonary arterial hypertension or right sided heart strain however recommend echocardiogram
first dose: dizziness, feeling of fainting w/in 5 mins p/receiving inject; sx progressed to diaphoretic, pain; running up arm into neck, severe h/a, chills, SOB, nervousness, cold feeling inside chest & hands, shaking; upset;
I broke out in an extremely itchy rash from my head to my feet. My lips felt numb and tingle. I suffered from a 24 hour period of insomnia. Extreme anxiety with massive mental racing thoughts that i couldn't control. Followed by 2 days of fatigue, body aches, head aches, muscle and joint pain. Loss of appetite with extreme diarrhea and abdominal pain.
At 7:15PM on Monday, 2/15/2021, I experienced blurred vision in the periphery of my right eye. At the same time, I felt some body tingling and mild numbness, most notably in my right fingertips. It lasted for approximately 3-5 minutes. After, the blurred vision and tingling dissipated, I had a mild headache across my forehead and eye socket area that felt like a pressure in the area. The mild headache continued when I woke up on Tuesday, 2/16/2021.
Triggered previous dormate nerve pain from trigeminal neurlgia. Causing intense facial pain. Which has resulted in weeks of missed work, inability to wear a mask, increased pain with covid testing. Seeked treatment from primary care dr, a facial pain specialist, and pain management anathesiologist. Treatments include, pain medication, botox, ketamine infusions, neurologiacal medications.  Currently had to fill for leave from work and took the max of COVID leave.
Had 2 an just getting over shingles; Had 2 an just getting over shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was recovered/resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.     Additional Information: GSK Receipt Date: 16th Apr 2022 Reporter's Comments: : This case was reported by a consumer via interactive digital media. The case was reported by patient. The patient stated that shot did not help. The patient had 2 shots of shingles and just got over shingles.  Additional Supportive Information: This case was considered as suspected vaccination failure since details regarding time to onset and laboratory confirmation of shingles not given. The follow up would not be possible since no contact details provided.
Brief tonic clonic seizure activity lasting for seconds. Pallor lasting about 30 seconds.
This case was reported by a consumer via call center representative and described the occurrence of headache in a adult female patient who received SHINGRIX for prophylaxis. The patient's past medical history included herpes zoster (started on  October 2017). On 27th March 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced headache, shivering, pain in arm, erythema and pain. On an unknown date, the outcome of the headache, shivering, pain in arm, erythema and pain were recovered/resolved. It was unknown if the reporter considered the headache, shivering, pain in arm, erythema and pain to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported. The patient experienced shivering, soreness, redness, pain and a headache. All those side effects listed lasted overnight, but the sore arm lasted about three days. For tolerence of 2nd dose refer case, US2018177101 reported by the same reporter for the same patient.
Patient complaint of numbness and swelling of her left side of the face after a month of H1N1 vaccine administration. Patient went to Hospital for the said symptom on 12/09/2009.
suspected sz or apnea 8hrs p/vax;2 days p/2nd DTP (mom didn't report rxn to 2nd DTP until episode following 3rd DTP);
Fever,  moderate body ache, headache, chest congestion, swollen axillary lymph nodes under left (injection site) arm for three+ days, increased resting heart rate, significant fatigue.  Mild injection site pain.
GAVE HEP A AND HPV 9 VALENT - VASOVAGAL REACTION.
The vaccinator must've hit the blood stream because I had a stream of blood go down my arm after the shot (I'm not a bleeder).  I've had a low grade fever, nausea, and exhaustion ever since.
This spontaneous report was received from a medical assistant refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions or medical history provided. The patient's concomitant therapies included sterile diluent. On 04-SEP-2018, the patient was vaccinated with an improperly stored dose of PROQUAD subcutaneous, lot # R011803, expiration date 21-OCT-2019 (dosage schedule, route and anatomical location were not reported) for prophylaxis. There was no adverse effect reported. The administered dose of vaccine experienced the temperature excursion of -9 to 8 degrees Celsius (-8.9) for 1 hour 29 minutes. The previous temperature excursion was -14 to -10 degrees Celsius for 4 hours and -9 to 8 degrees Celsius for 4 hours 34 minutes. Data logger was involved.
Breakthrough case admission after 2 vaccines Moderna 4/9/21 Lot# 025B21A;  Moderna 5/12/21 Lot# 005C21A
COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 25052C21A) for COVID-19 vaccination.     Concurrent medical conditions included GERD. Concomitant products included OMEPRAZOLE for an unknown indication.    On 24-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (COVID-19). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) from 19-May-2022 to 24-May-2022 for COVID-19, at an unspecified dose and frequency. At the time of the report, COVID-19 (COVID-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-May-2022, SARS-CoV-2 test: negative (Negative) Negative and positive (Positive) Positive.         The patient previously received a COVID-19 Vaccine.  The indication for Paxlovid was Treatment of COVID-19.  The device date was provided as 28-May-2022.  Company comment: This spontaneous case concerns a 39-year-old male patient with no relevant medical history, who experienced the unexpected non-serious AESI of Covid-19, seven months after receiving mRNA-1273 vaccine as 3rd dose. The patient was treated with Paxlovid (Nirmatrelvir + Ritonavir) for Covid-19. Two and a half days after finishing the course, the patient tested positive for SARS-CoV-2 test. The outcome was reported as unknown. Details of symptoms, clinical course, further investigation reports and treatment were not provided. Details of previous two doses were not provided. The current pandemic situation of Covid-19 could be a confounder. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Sender's Comments: This spontaneous case concerns a 39-year-old male patient with no relevant medical history, who experienced the unexpected non-serious AESI of Covid-19, seven months after receiving mRNA-1273 vaccine as 3rd dose. The patient was treated with Paxlovid (Nirmatrelvir + Ritonavir) for Covid-19. Two and a half days after finishing the course, the patient tested positive for SARS-CoV-2 test. The outcome was reported as unknown. Details of symptoms, clinical course, further investigation reports and treatment were not provided. Details of previous two doses were not provided. The current pandemic situation of Covid-19 could be a confounder. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
patient reported severe neuropathy bilateral legs and feet, dizziness, nausea very similar to 3 years ago when she was on chemotherapy for breast cancer. Neuropathy had resolved.
Adult patient received undiluted pediatric formulation of pfizer COVID vaccine. Per pt, as of 24 hr after vaccination, only s/sx are mild arm soreness.
booster side effects; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION COMPLICATION (booster side effects) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (booster side effects). At the time of the report, VACCINATION COMPLICATION (booster side effects) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were reported   No treatment information was reported
Reaction: swelling  on upper left arm at injection site and redness; pain that radiated from the injection site up to the base of the skull and down to the fingertips Treatment: ice (made it worse); heat (helped for 30 minutes at a time); ibuprofen (helped for about an hour); Bactrim (after 3 days swelling decreased and redness cleared) doctor diagnosed me with an infection at the site Outcome: After 3 days on Bactrim the swelling and redness have cleared, but the pain remains
3:56pm- 71/F in post vaccination area witnessed multiple episodes of vomiting yellow emesis. Appears diaphoretic, initial BP 220/110, HR 110. O2 95%, RR 22. Pt received the vaccine at 3:46pm. She denies blurred vision, no headache, no chest pain or SOB. Denies abdominal pain but her daughter states she recently had a hernia repair and has had issues with cyclic vomiting induced with certain foods or stress, which her doctors are monitoring her for. Her daughter states she was feeling sick before she got her vaccine. Patient states she took her morning medication at 7am, had some breakfast at 10am and states she feels it was some pineapple she ate that caused her to start feeling nauseous. She adds that she is taking several blood pressire medications but when she begins to vomting her blood pressure "gets really high." Pt is AOx4, able to speak in clear complete sentences.  4:05pm- BP 210/120, HR 82, 97%, RR 24. Pt continues to vomit intermittently but states she is starting to feel better. Onsite nurse manager, lead and site lead aware. EMS services requested. 4:10pm- BP 191/100, HR 86,  96%. No vomiting witnessed. 4:14pm- Ems arrives on scene. BP sitting 156/91, standing 140/92. Pt states she feels better. Parameduc offers to transfer her to the hospital but patient declines. Her daughter is at side and she states she would rather her daughter take her home since she is feeling better. Educated regarding when to seek medical attention. Pt AOx4, resp even, skin warm and dry, not actively vomiting, speaks in clear complete sentences. Assisted to POV via wheelchair. Pt in no apparent distress.
Within 24hrs of vaccine, developed fever to 101, treated with 1 dose of TYLENOL. Within 48hrs, developed projectile vomiting, lethargy, episodes of drawing legs up with intense screaming, blood in stool. Bloody, mucus stools continued intermittently for 3.5 weeks post vaccine administration. Seen by GI specialist who recommended starting probiotic; remained on nutramigen the entire course. After almost 4 weeks, stools returned to normal.
Fever, lymphadenopathy, parotid gland enlargement on right, 17 days, post vax. Treated with Advil, Tylenol per PNP. On 2/6/01, improving with no other problems.
This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy) and PAIN IN EXTREMITY (Sore arm) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced DIZZINESS (Dizzy) and PAIN IN EXTREMITY (Sore arm). On 17-Feb-2021, PAIN IN EXTREMITY (Sore arm) had resolved. At the time of the report, DIZZINESS (Dizzy) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. On 18-Feb-2021, the patient was dizzy again but not very bad. No concomitant medications were reported. No treatment medications were reported.
This spontaneous report as received from a nurse practitioner refers to her daughter (age not reported). On an unknown date in 2008 the patient was vaccinated with booster dose of VARIVAX (Merck) subcutaneous (lot #, dose, strength, site and route of administration not reporter). Concomitant therapies included vitamins (unspecified), OMEGA-3 and high doses (not specified) of vitamin d (unspecified). The reporter stated that her twins, boy (captured in MARRS # 1403USA007224) and girl experienced severe reactions after vaccination with booster dose of VARIVAX (Merck). On an unknown date in 2008 the patient experienced generalized lymphadenopathy and very large urticaria on her thigh which covered her almost entire thigh and profuse itching. Her daughter also experienced bruising, petechia and profuse nose bleeds following VARIVAX (Merck) vaccination and these symptoms lasted for several days. About a month after vaccination with VARIVAX (Merck) had another giant urticaria in her arm had similar nose bleeding and bruising issues. Nurse practitioner stated that these bleeding symptoms improved somewhat after several days but her daughter intermittently experienced nosed bleeds and bruising for about a year following vaccination. About a year after VARIVAX (Merck) dose, her daughter was tested and found to have abnormal platelet function and her platelet level dropped. The outcome of generalized lymphadenopathy, platelet level dropped, abnormal platelet function, petechia, profuse itching and very large urticaria on her thigh was not reported. The relatedness between generalized lymphadenopathy, platelet level dropped, abnormal platelet function, petechia, nose bleeding, bruising profuse itching and very large urticaria on her thigh and therapy with VARIVAX (Merck) was unknown. The reporter stated that her children were very sensitive to vaccines and she's been closely working with allergist and immunologist to find the cause for these reactions. This is one of two same patient cases from the same source (second case MARRS # 1403USA007227). This is one of several cases from the same source (other cases MARRS # 1403USA007224, 1403USA007225, 1403USA003195, 1403USA007227, 1403USA007228). Additional information is not expected.
Patient received vaccine and fainted several minutes after receiving dose.  When patient retained consciousness he was having difficulty speaking and was having difficulty breathing and kept repeating that he couldn?t breath, a dose of epinephrine through an Epi pen was administered 911 was called the patients vitals were checked and he chose not to leave in an ambulance and left
pt received J&J, unsure of dose or vaccine site, pt has rash on right ear lobe 2 days after her covid vaccine
Information has been received from a 23 year old female who on 03-OCT-2006 was vaccinated with a 0.5 mL dose of GARDASIL. The patient reported that the vaccine was given in the front part of the thigh muscle. Subsequently, the muscle contracted and the patient passed out due to pain. Unspecified medical attention was sought. When the patient woke up, she reported that she "felt fine." On 03-OCT-2006, the patient recovered from the events. Additional information is not expected.
Narrative:  Patient was hospitalized in med unit on 5/17/2021 d/t AMS 2/2 overmedication. Documenting VAERS d/t proximity of COVID-19 MODERNA vaccine and hospitalization. No reported ADR since vaccination.
expired VAQTA was administered to a patient; This spontaneous report was received from a nurse referring to a patient of unknown age.  No information was provided regarding the patient's medical history, concurrent conditions, drug reactions/allergies or concomitant medications.  On 16-OCT-2020, the patient was vaccinated with hepatitis a vaccine, inactivated (VAQTA) for prophylaxis (dose, route and site of administration and lot number were not reported).  The vaccine had expired on 24-AUG-2020 (expired product administered) and had not undergone a prior temperature excursion.    The outcome of expired product administered was unknown.
itching at the injection site; lumps on her left arm / lumps at the injection site; This case was reported by a consumer via call center representative and described the occurrence of injection site itching in a 76-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 4th March 2020, the patient received the 2nd dose of Shingrix (intramuscular). On an unknown date, less than 9 months after receiving Shingrix, the patient experienced injection site itching and injection site lump. On an unknown date, the outcome of the injection site itching and injection site lump were recovered/resolved.   It was unknown if the reporter considered the injection site itching and injection site lump to be related to Shingrix.  Additional details were provided as follows:  The patient reported for herself. The patient had lumps and itching at the injection site (left arm). The events lasted for 3 months. The reporter consented to follow up.
Headache began 12 PM 4/3/2021. Lasted 3 days Fever began 12 PM 4/3/2021. HIghest temperature was 101.8 . Lasted 20 hours Chills began 1 PM 4/3/2021 lasted 18 hours Red swollen arm began about 36 hours following injection. Red swollen arm is 3 inches below injection site, about 3 inches in diameter with knot in the center, Lump went away within 36 hours and redness remains as of 4/4/8/2021
My left eye hurts and feels like it's twitching. It is also getting puffy and once in a while a sharp pain shoots through my eye. Thanks.
improvement in her ability to breath/ increase in energy level; Reports an increase in energy level; This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (improvement in her ability to breath/ increase in energy level) and ENERGY INCREASED (Reports an increase in energy level) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025C21A) for COVID-19 vaccination.     Concurrent medical conditions included Congestive heart failure.    On 12-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Aug-2021, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (improvement in her ability to breath/ increase in energy level) and ENERGY INCREASED (Reports an increase in energy level). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (improvement in her ability to breath/ increase in energy level) and ENERGY INCREASED (Reports an increase in energy level) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Medical history also included a "TENS unit for my heart" in her left arm.   Concomitant product use was not reported.  Patient reported that she has a history of congestive heart failure and used to have trouble with her breathing and would pass out. After her first dose of the vaccine, she reported that her breathing was better and her whole body seemed to have more energy.  Treatment information was not provided.